Impact of the nitric oxide substrate l-arginine alone and combined with atropine on malathion neuro and hepato-toxicity
Abstract
Objectives
We investigated the impact of the nitric oxide substrate l-arginine on the neuro- and hepato-toxic effects of malathion in rats.
Methods
Rats were treated intraperitoneally with malathion (150 mg/kg) alone or combined with l-arginine (100, 200 or 400 mg/kg), atropine (2 mg/kg) or l-arginine (200 mg/kg) combined with atropine (2 mg/kg). Rats were euthanized 4 h later, and their brains and livers analyzed for malondialdehyde, nitric oxide (NO), reduced glutathione (GSH), paraoxonase-1 (PON-1). Moreover, butyrylcholinesterase (BChE), interleukin-15 (IL-15) and anti-apoptotic protein B cell/lymphoma-2 (Bcl-2) were determined in brain tissue. Histopatholoy was also performed.
Results
Malathion significantly raised brain NO and malondialdehyde alongside with a notable drop in PON-1 activity and GSH levels relative to the saline control. Brain BChE and Bcl-2 were markedly inhibited whereas IL-15 significantly increased by malathion. In brain, l-arginine treatment resulted in a significantly increased malondialdehyde, decreased GSH, and increased IL-15. A significant decrease in liver malondialdehyde occurred by l-arginine/atropine or atropine. In contrast, l-arginine, l-arginine/atropine or atropine caused a significant decrease in brain and liver NO levels and increased PON-1 activity. Bcl-2 in brain significantly increased by atropine. Malathion induced brain neuronal and liver degeneration showed marked improvement after atropine alone.
Conclusions
These results indicated that exogenously administered l-arginine did not protect against the neuro- and hepto-toxic effects of malathion. Meanwhile, the ability of atropine to mitigate the deleterious effects of a toxic dose of malathion provides a strong support to the role of excessive stimulation cholinergic pathways in inflicting such damage.
Acknowledgments
We thank National Research Centre
-
Research ethics: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The National rules regarding animal welfare: U.S. National Institutes of Health’s Guide for Care and Use of Laboratory Animals’ requirements (Publication No. 85-23, revised 1996) were followed.
-
Informed consent: Not applicable.
-
Author contributions: AS conceived the study, HF collected the data, ERY, HF did the biochemical analysis and the plagiarism. OAS wrote the manuscript. All authors reviewed, and proofread the final manuscript.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: None.
-
Research funding: None.
-
Data availability: The data and materials used in this study are available upon request from the authors.
References
1. Sakata, M. Organophosphorus pesticides. In: Drugs and Poisons in Humans. Berlin, Heidelberg: Springer; 2005:535–44.10.1007/3-540-27579-7_60Search in Google Scholar
2. Mileson, BE, Chambers, JE, Chen, WL, Dettbarn, W, Ehrich, M, Eldefrawi, AT, et al.. Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci 1998;41:8–20. https://doi.org/10.1093/toxsci/41.1.8.Search in Google Scholar
3. Eddleston, M, Buckley, NA, Eyer, P, Dawson, AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008;371:597–607. https://doi.org/10.1016/s0140-6736(07)61202-1.Search in Google Scholar
4. Jokanović, M. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett 2009;190:107–15. https://doi.org/10.1016/j.toxlet.2009.07.025.Search in Google Scholar PubMed
5. Buckley, NA1, Eddleston, M, Li, Y, Bevan, M, Robertson, J. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2011:CD005085. https://doi.org/10.1002/14651858.CD005085.pub2.Search in Google Scholar PubMed
6. Jokanović, M, Stukalov, PV, Kosanovic, M. Organophosphate induced delayed polyneuropathy. Curr Drug Targets: CNS Neurol Disord 2002;1:593–602. https://doi.org/10.2174/1568007023338879.Search in Google Scholar PubMed
7. Jokanović, M, Kosanović, M. Neurotoxic effects in patients poisoned with organophosphorus pesticides. Environ Toxicol Pharmacol 2010;29:195–201. https://doi.org/10.1016/j.etap.2010.01.006.Search in Google Scholar PubMed
8. Narayan, S, Liew, Z, Paul, K, Lee, PC, Sinsheimer, JS, Bronstein, JM, et al.. Household organophosphorus pesticide use and Parkinson’s disease. Int J Epidemiol 2010;42:1476–85. https://doi.org/10.1093/ije/dyt170.Search in Google Scholar PubMed PubMed Central
9. Wang, A, Cockburn, M, Ly, TT, Bronstein, JM, Ritz, B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup Environ Med 2014;71:275–81. https://doi.org/10.1136/oemed-2013-101394.Search in Google Scholar PubMed PubMed Central
10. Pearson, JN, Patel, M. The role of oxidative stress in organophosphate and nerve agent toxicity. Ann N Y Acad Sci 2016;1378:17–24. https://doi.org/10.1111/nyas.13115.Search in Google Scholar PubMed PubMed Central
11. Floyd, RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236–45. https://doi.org/10.1046/j.1525-1373.1999.d01-140.x.Search in Google Scholar PubMed
12. Förstermann, U, Sessa, WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33:829–37d. https://doi.org/10.1093/eurheartj/ehr304.Search in Google Scholar PubMed PubMed Central
13. Moncada, S, Bolanos, JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006;97:1676–89. https://doi.org/10.1111/j.1471-4159.2006.03988.x.Search in Google Scholar PubMed
14. Bayir, H, Kagan, VE, Clark, RS, Janesko-Feldman, K, Rafikov, R, Huang, Z, et al.. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 2007;101:168–81. https://doi.org/10.1111/j.1471-4159.2006.04353.x.Search in Google Scholar PubMed
15. Abdel-Salam, OME, Youness, ER, Mohammed, NA, Yassen, NN, Khadrawy, YA, El-Toukhy, SE, et al.. Nitric oxide synthase inhibitors protect against brain and liver damage caused by acute malathion intoxication. Asian Pac J Tropical Med 2017;10:773–86. https://doi.org/10.1016/j.apjtm.2017.07.018.Search in Google Scholar PubMed
16. Abdel-Salam, OM, Youness, ER, Mohammed, NA, Yassen, NN, Khadrawy, YA, El-Toukhy, SE, et al.. Novel neuroprotective and hepatoprotective effects of citric acid in acute malathion intoxication. Asian Pac J Tropical Med 2016;9:1181–94. https://doi.org/10.1016/j.apjtm.2016.11.005.Search in Google Scholar PubMed
17. Sudar-Milovanovic, E, Obradovic, M, Jovanovic, A, Zaric, B, Zafirovic, S, Panic, A, et al.. Benefits of L-arginine on cardiovascular system. Mini Rev Med Chem 2016;16:94–103. https://doi.org/10.2174/1389557515666151016125826.Search in Google Scholar PubMed
18. Gambardella, J, Khondkar, W, Morelli, MB, Wang, X, Santulli, G, Trimarco, V. Arginine and endothelial function. Biomedicines 2020;8:277. https://doi.org/10.3390/biomedicines8080277.Search in Google Scholar PubMed PubMed Central
19. Böger, RH, Bode-Böger, SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001;41:79–99. https://doi.org/10.1146/annurev.pharmtox.41.1.79.Search in Google Scholar PubMed
20. Colagrande, L, Formica, F, Porta, F, Keshavarzian, O, Azari, I, Abdollahi, M, et al.. L-arginine effects on myocardial stress in cardiac surgery: preliminary results. Ital Heart J 2005;6:904–10.Search in Google Scholar
21. McNeal, CJ, Meininger, CJ, Reddy, D, Wilborn, CD, Wu, G. Safety and effectiveness of arginine in adults. J Nutr 2016;146:2587S–2593S. https://doi.org/10.3945/jn.116.234740.Search in Google Scholar PubMed
22. Chambers, JE, Meek, EC. Chambers HW the metabolism of organophosphorus insecticides. In: Krieger, RI, editor. Hayes’ Handbook of Pesticide Toxicology. San Diego, CA: Academic Press; 2010:1309–407 pp.10.1016/B978-0-12-374367-1.00065-3Search in Google Scholar
23. Paget, GE, Barnes, JM. Toxicity tests. In: Laurence, DR, Bacharach, AL, editors. Evaluation of drug activities. Pharmacometrics. London: Academic Press; 1964:p161 p.10.1016/B978-1-4832-2845-7.50012-8Search in Google Scholar
24. Patel, P, McLendon, K, Preuss, CV. Atropine. In: StatPearls [Internet], [Updated 2025 Jul 6]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470551/.Search in Google Scholar
25. Piel, S, Janowska, JI, Ward, JL, McManus, MJ, Jose, JS, Starr, J, et al.. Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoning. Sci Rep 2022;12:20329. https://doi.org/10.1038/s41598-022-24472-3.Search in Google Scholar PubMed PubMed Central
26. Ruiz-Larrea, MB, Leal, AM, Liza, M, Lacort, M. de Groot H Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 1994;59:383–8. https://doi.org/10.1016/0039-128x(94)90006-x.Search in Google Scholar PubMed
27. Ellman, GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1995;82:70–7. https://doi.org/10.1016/0003-9861(59)90090-6.Search in Google Scholar PubMed
28. Moshage, H, Kok, B, Huizenga, JR. Jansen PL nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41:892–6. https://doi.org/10.1093/clinchem/41.6.892.Search in Google Scholar
29. Higashino, K, Takahashi, Y, Yamamura, Y. Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride. Clin Chim Acta 1972;41:313–20. https://doi.org/10.1016/0009-8981(72)90526-8.Search in Google Scholar PubMed
30. Kousar, F, Jahan, N, Rahman, KU, Sultana, B. Optimization of parameters for the formulation of Moringa oleifera nanosuspension with enhanced hepatoprotective potential. Pakistan J Agric Sci 2024;61:116–27.Search in Google Scholar
31. Asif, I, Mohyud Din, MT, Ijaz, M, Manzoor, A, Hassan, F, Mehmood, MS, et al.. Evidence based investigation of the hepatoprotective potential of Orange peel and banana peel. Pakistan J Agric Sci 2024;61:695–702.Search in Google Scholar
32. Trevisan, R, Uliano-Silva, M, Pandolfo, P, Franco, JL, Brocardo, PS, Santos, AR, et al.. Antioxidant and acetylcholinesterase response to repeated malathion exposure in rat cerebral cortex and hippocampus. Basic Clin Pharmacol Toxicol 2008;102:365–9. https://doi.org/10.1111/j.1742-7843.2007.00182.x.Search in Google Scholar PubMed
33. Durak, D, Uzun, FG, Kalender, S, Ogutcu, A, Uzunhisarcikli, M, Kalender, Y. Malathion-induced oxidative stress in human erythrocytes and the protective effect of vitamins C and E in vitro. Environ Toxicol 2009;24:235–42. https://doi.org/10.1002/tox.20423.Search in Google Scholar PubMed
34. Kaur, P, Radotra, B, Minz, RW, Gill, KD. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 2007;28:1208–19. https://doi.org/10.1016/j.neuro.2007.08.001.Search in Google Scholar PubMed
35. Middlemore-Risher, ML, Adam, BL, Lambert, NA, Terry, AVJr. Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons. J Pharmacol Exp Therapeut 2011;339:341–9. https://doi.org/10.1124/jpet.111.184762.Search in Google Scholar PubMed PubMed Central
36. Lenaz, G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001;52:159–64. https://doi.org/10.1080/15216540152845957.Search in Google Scholar PubMed
37. Genova, ML, Pich, MM, Bernacchia, A, Bianchi, C, Biondi, A, Bovina, C, et al.. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann N Y Acad Sci 2004;1011:86–100. https://doi.org/10.1196/annals.1293.010.Search in Google Scholar
38. Bains, JS, Shaw, CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 1997;25:335–58. https://doi.org/10.1016/s0165-0173(97)00045-3.Search in Google Scholar PubMed
39. Cnubben, NH, Rietjens, IM, Wortelboer, H, van Zanden, J. Van bladeren PJ the interplay of glutathione-related processes in antioxidant defense. Environ Toxicol Pharmacol 2001;10:141–52. https://doi.org/10.1016/s1382-6689(01)00077-1.Search in Google Scholar PubMed
40. Pacher, P, Beckman, JS, Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424. https://doi.org/10.1152/physrev.00029.2006.Search in Google Scholar PubMed PubMed Central
41. Costa, LG, Li, WF, Richter, RJ, Shih, DM, Lusis, A, Furlong, CE. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Chem Biol Interact 1999;119-120:429–38. https://doi.org/10.1016/s0009-2797(99)00055-1.Search in Google Scholar PubMed
42. Furlong, CE, Marsillach, J, Jarvik, GP. Costa LG Paraoxonases-1,-2 and -3: what are their functions? Chem Biol Interact 2016;259:51–62. https://doi.org/10.1016/j.cbi.2016.05.036.Search in Google Scholar PubMed PubMed Central
43. Abdel-Salam, OME, Galal, AF, Hassanane, MM, Salem, LM, Nada, SA, Morsy, FA. Grape seed extract alone or combined with atropine in treatment of malathion induced Neuro-and genotoxicity. J Nanosci Nanotechnol 2018;18:564–75. https://doi.org/10.1166/jnn.2018.13943.Search in Google Scholar PubMed
44. Nguyen, SD, Hung, ND, Cheon-Ho, P, Ree, KM, Dai-Eun, S. Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1). Biochim Biophys Acta 2009;1790:155–60. https://doi.org/10.1016/j.bbagen.2008.11.009.Search in Google Scholar PubMed
45. Shih, DM, Gu, L, Xia, YR, Navab, M, Li, WF, Hama, S, et al.. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284–7. https://doi.org/10.1038/28406.Search in Google Scholar PubMed
46. Li, WF, Costa, LG, Richter, RJ, Hagen, T, Shih, DM, Tward, A, et al.. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 2000;10:767–79. https://doi.org/10.1097/00008571-200012000-00002.Search in Google Scholar PubMed
47. Furlong, CE, Li, WF, Brophy, VH, Jarvik, GP, Richter, RJ, Shih, DM, et al.. The PON1 gene and detoxication. Neurotoxicology 2000;21:581–7.Search in Google Scholar
48. Wang, NN, Dai, H, Yuan, L, Han, ZK, Sun, J, Zhang, Z, et al.. Study of paraoxonase-1 function on tissue damage of dichlorvos. Toxicol Lett 2010;196:125–32. https://doi.org/10.1016/j.toxlet.2010.04.008.Search in Google Scholar PubMed
49. Laurent, C, Deblois, G, Clénet, ML, Carmena Moratalla, A, Farzam-Kia, N, Girard, M, et al.. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE. Neurol Neuroimmunol Neuroinflamm 2020;8:e931. https://doi.org/10.1212/NXI.0000000000000931.Search in Google Scholar PubMed PubMed Central
50. Pan, W, Wu, X, He, Y, Hsuchou, H, Huang, EY, Mishra, PK, et al.. Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev 2013;37:184–92. https://doi.org/10.1016/j.neubiorev.2012.11.009.Search in Google Scholar PubMed PubMed Central
51. Zhai, D, Jin, C, Huang, Z, Satterthwait, AC, Reed, JC. Differential regulation of bax and bak byanti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem 2008;283:9580–6. https://doi.org/10.1074/jbc.m708426200.Search in Google Scholar
52. Li, J, Yuan, J. Caspases in apoptosis and beyond. Oncogene 2008;27:6194–206. https://doi.org/10.1038/onc.2008.297.Search in Google Scholar PubMed
© 2025 Walter de Gruyter GmbH, Berlin/Boston